Morgan Stanley Nuvalent, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Nuvalent, Inc. stock. As of the latest transaction made, Morgan Stanley holds 471,717 shares of NUVL stock, worth $39.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

471,717

Previous 386,657 22.0%

Holding current value

$39.7 Million

Previous $29.3 Million 64.52%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.44 - $112.17 $5.74 Million - $9.54 Million	85,060 Added 22.0%	471,717 $48.3 Million
Q2 2024 Oct 17, 2024	BUY	$62.76 - $81.61 $12.7 Million - $16.5 Million	201,986 Added 109.38%	386,657 $29.3 Million
Q2 2024 Aug 14, 2024	BUY	$62.76 - $81.61 $12.7 Million - $16.5 Million	201,986 Added 109.38%	386,657 $29.3 Million
Q1 2024 Oct 17, 2024	SELL	$72.35 - $88.99 $14.6 Million - $18 Million	-201,986 Reduced 52.24%	184,671 $13.9 Million
Q1 2024 Aug 16, 2024	SELL	$72.35 - $88.99 $6.4 Million - $7.87 Million	-88,452 Reduced 32.39%	184,671 $13.9 Million
Q1 2024 May 15, 2024	SELL	$72.35 - $88.99 $6.4 Million - $7.87 Million	-88,452 Reduced 32.39%	184,671 $13.9 Million
Q4 2023 Aug 16, 2024	SELL	$42.42 - $80.28 $4.82 Million - $9.11 Million	-113,534 Reduced 29.36%	273,123 $20.1 Million
Q4 2023 Feb 13, 2024	BUY	$42.42 - $80.28 $4.28 Million - $8.1 Million	100,890 Added 58.58%	273,123 $20.1 Million
Q3 2023 Nov 15, 2023	BUY	$39.12 - $49.85 $3.74 Million - $4.76 Million	95,564 Added 124.64%	172,233 $7.92 Million
Q2 2023 Aug 14, 2023	BUY	$23.58 - $44.68 $98,988 - $187,566	4,198 Added 5.79%	76,669 $3.23 Million
Q1 2023 May 15, 2023	SELL	$25.42 - $33.52 $121,050 - $159,622	-4,762 Reduced 6.17%	72,471 $1.89 Million
Q4 2022 Feb 14, 2023	BUY	$18.46 - $36.37 $359,619 - $708,523	19,481 Added 33.73%	77,233 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$13.55 - $19.92 $98,874 - $145,356	-7,297 Reduced 11.22%	57,752 $1.12 Million
Q2 2022 Oct 27, 2022	BUY	$7.4 - $15.07 $298,915 - $608,737	40,394 Added 163.84%	65,049 $883,000
Q2 2022 Aug 15, 2022	BUY	$7.4 - $15.07 $298,915 - $608,737	40,394 Added 163.84%	65,049 $883,000
Q1 2022 Oct 27, 2022	SELL	$11.65 - $19.57 $470,590 - $790,510	-40,394 Reduced 62.1%	24,655 $342,000
Q1 2022 May 13, 2022	BUY	$11.65 - $19.57 $184,035 - $309,147	15,797 Added 178.34%	24,655 $342,000
Q4 2021 Feb 14, 2022	BUY	$18.01 - $30.1 $142,999 - $238,994	7,940 Added 864.92%	8,858 $169,000
Q3 2021 Nov 15, 2021	BUY	$18.25 - $38.35 $16,753 - $35,205	918 New	918 $21,000

Others Institutions Holding NUVL

# of Institutions

209

Shares Held

59.5M

Call Options Held

450K

Put Options Held

619K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.62B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account